Publication Year

ApSimon M, Steel C, Johnston C, Winder B, Cohen S, Reichert H, Armstrong D. 2024. Enteral nutrition on discharge from intensive care and 30-day unplanned readmission: An exploratory, retrospective study of association. Clin Nutr ESPEN 61(June):15-21. doi: 10.1016/j.clnesp.2024.03.002.

Blatt AZ, Suh M, Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Geographic progression of infant respiratory syncytial virus associated bronchiolitis across the United States before and since the onset of COVID-19: Results from four health systems, 2015-2023. Influenza Other Respir Viruses 18(5):e13298; doi: 10.1111/irv.13298. PMID: 387511.

Reddam A, Bloomquist TR, Covell LT, Heng H, Oberfield SE, Gallagher D, et al. 2024. Negative associations of cord blood mitochondrial DNA copy number with childhood adiposity. Obesity. 32(5):989–998; doi: 10.1002/oby.24005. PMID: 38454311.

Blatt AZ, Suh M, Walter EB Jr, Wood CT, Espinosa C, … Movva N, Reichert H, Fryzek JP, Nelson CB. 2024. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023. Ann Epidemiol 94(June):72–80; doi: 10.1016/j.annepidem.2024.04.010.

Wikoff D, Fitch S. 2024. Evidence‐based methods in toxicology: Systematic review and systematic evidence mapping. Chapter 32 in: Paustenbach DJ (ed), Human and Ecological Risk Assessment: Theory and Practice, Third Edition, pp. 1133–1148. Wiley, ISBN: 978-1-119-74296-8.

Doepker C, Rabert C, Heard P, Dubnicka T, Choksi N, Eapen A. 2024. An investigation of the genotoxic potential of a well-characterized yerba mate extract. Toxicol Rep 12(June):477–484; doi: 10.1016/j.toxrep.2024.04.007.

Mihalchik AL, Choksi NY, Roe AL, Wisser M, Whitaker K, Seibert D, Deore M, Pavlick L, Wikoff DS. 2024. Safety evaluation of 8 drug degradants present in over-the-counter cough and cold medications. Regul Toxicol Pharmacol 149(May):105621; doi: 10.1016/j.yrtph.2024.105621. PMID: 38608922.

Yoshino T, Hooda N, Younan D, Muro K, Shitara K, Heinemann V,… Suh M, Reichert H, Mezzi K, Fryzek J, et al. 2024. A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness. Eur J Cancer 202:113975; doi: 10.1016/j.ejca.2024.113975. PMID:  38442645.

Nelms MD, Antonijevic T, Ring C, Harris DL, Bever RJ, Lynn SG, … Borghoff S, et al. 2024. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models. Front Toxicol 6(April 17):1346767; https://doi.org/10.3389/ftox.2024.1346767. PMID: 38694816.

Mittal L, Perry CS, Blanchette AD, Proctor DM. 2024. Probabilistic risk assessment of residential exposure to electric arc furnace steel slag using Bayesian model of relative bioavailability and PBPK modeling of manganese. Risk Anal. 44(9):2169-2186. doi: 10.1111/risa.14309. PMID: 38622492.

Suh M, Movva N, Jiang X, Reichert H, Pastula ST, Sacks NC, Frankenfeld C, Fryzek JP, Simões AF. 2024. Healthcare utilization among infants covered by Medicaid and newly diagnosed with respiratory syncytial virus. Open Forum Infect Dis 11(4)::ofae174; doi: 10.1093/ofid/ofae174. PMID: 38595954.

Heintz MM, Klaren WD, East AW, Haws LC, McGreal SR, Campbell RR, Thompson CM. 2024. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes. Toxicol Sci 200(1):165–182; doi: 10.1093/toxsci/kfae044.  PMID: 38574381.

Heintz MM, Klaren WD, East AW, Haws LC, McGreal SR, Campbell RR, Thompson CM. 2024. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes. Toxicol Sci 200(1):183–198; doi: 10.1093/toxsci/kfae045. PMID: 38574385.

Laurer D, Benson S, Marshall L, Wood L, Keeton K, Steigerwald D, Dobyns L, Finley B. Asbestos and laryngeal cancer: A fiber-type specific meta-analysis. Abstract 3392, poster presentation at Society of Toxicology 63^rd Annual Meeting, Salt Lake City, UT, 2024.

Ierardi AM, Burns A, Urban A, Finley B. 2024. A risk assessment of cosmetic talc for the development of mesothelioma and ovarian cancer. Chapter 13 in: Paustenbach DJ (ed), Human and Ecological Risk Assessment: Theory and Practice, Third Edition. Wiley, ISBN: 978-1-119-74296-8, pp. 541–570.

Hirani RN, Bare JL, Mathis C. 2024. Health risk assessment of consumer products: Case studies of DEHP exposure from disposable plastic packaging and formaldehyde exposure from a residential couch. Chapter 11 in: Paustenbach DJ (ed), Human and Ecological Risk Assessment: Theory and Practice, Third Edition. Wiley, ISBN: 978-1-119-74296-8, pp. 499–524.

Kougias DG, Killius A, Collins J, Russman E, Maddaloni M. 2024. Per- and polyfluoroalkyl substances (PFAS) in drinking water: A retrospective case series with risk assessments. Chapter 7 in: Paustenbach DJ (ed), Human and Ecological Risk Assessment: Theory and Practice, Third Edition. Wiley, ISBN: 978-1-119-74296-8, pp. 337–396.

Burnett J, Sychterz C, Zhu D, Shakeel F, Dingley K, Chen W, et al. Prospective application of physiologically based pharmacokinetic (PBPK) modeling to inform the design of a clinical drug-drug interaction (DDI) study: Case study of mezigdomide. Poster presented at American Society of Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, Colorado Springs, CO, March 2024.

Williams Z, Covell L, Tung P, Bloomquist TR, Schilling K, Deyssenroth M, et al. Investigating the influence of prenatal metals exposures on childhood mitochondrial biomarkers. Poster presentation P532 at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. In: The Toxicologist 198(S1):223, Abstract 3389.

Madl AK, Donnell MT, Covell L. Synthetic vitreous fibers (SVFs): Adverse outcome pathways (AOPs) and considerations for new generation new approach methods (NAMs). Poster presentation P863 at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. In: The Toxicologist 198(S1):492, Abstract 4288.